Posts tagged “Quintiles”
Given the mammoth size of India's population, drug testing firms such as Quintiles have targeted the country for trials. But Quintiles, the world's largest life science services firm, has shut down an early-stage test group. As to why, the Durham-based company doesn't have much to say. The Supreme Court of India is up in arms about testing.
The MDA has struck an agreement with Quintiles, the world's largest life science services firm, to help the organization build a registry through which it hopes to advance the fight against muscular dystrophy and other diseases.
Quintiles (NYSE:Q) wants to find out if "pre-profiling" cancer patients to to get the genomic profile of tumors can help develop better, more targeted cancer therapies. Read more about a studt its doing with US Oncology Research.
The world's largest life science services firm is crunching big data in thousands of ways with the goal of helping clients develop and deliver drugs more quickly. It's also one of 12 winners in Computerworld's first "Data+ Editor's Choice Awards." To sweeten the honor, Q's data team is featured on the magazine's cover. In an exclusive interview, WRALTechWire talks with Q's CIO about the project, the importance of big, clean data, and the award.
"This is part of our strategic investment plan for the business in North America," a company spokesman says. "Cheminova's business in the region grew 23 percent in 2012, and has also shown positive growth thus far in 2013."
Quintiles CEO Tom Pike ventured into a Wall Street lion's den on Monday for a live interview with CNBC Mad Money host Jim Cramer. But rather than facing a mauling, Pike jousts in a friendly fashion with Cramer, who professes he likes the big "Q."
Quintiles' acquisition of Novella Clinical gives the CRO industry's largest player a missing piece. Executives from both companies discuss the deal in an exclusive for WRALTechWire Insiders.
Quintiles, the world's largest life science services firm, is growing even larger with the acquisition of a nearby competitor - Novella Clinical.
Don't be surprised if the big "Q" gets even bigger - soon. Wall Street loves Quintiles after a strong earnings report, and its stock price remains more than 10 percent above its May IPO price. Now the Durham-based life science services firm is looking to enhance its growth with more deals.
The N.C. Biotech Center notes recent wins of three Triangle life science firms whose start included support from the Biotech Center
Clinical trial services are Quintiles' bread and butter but the CRO industry's largest company sees other growth opportunities. Read more about Quintiles strategy.
While pharmas, payers and providers have historically operated in silos, collaborations will be key for the future of health care, according to a new Quintiles report.
Biotech IPOs represented 13 of the 21 venture-capital companies that went public in the second quarter. Get more more details of an analysis of second quarter IPOs.
Several high-tech and life science firms based in North Carolina or who have a large presence here crack the "Best Multinationals" to work for list in Europe. But several of them also drop somewhat from the 2012 list.
The RX for a healthier bottom line at the world's largest life science services firm includes better employee health. A new award in the U.K. honors Quintiles for its commitment to a healthy workplace. WRALTechWire's exclusive interview with the associate director of Quintiles Employee Health Management provides the inside story.
Quintiles stock has consistently traded above its $43 per share IPO price. Read how analysts are rating the stock of the Durham CRO.